Phone
Email
ClinicalTrials.gov URL
Acknowledgement
3 business days
EA Policies for Single Patient
General Policy
Faron Pharmaceuticals does not have an open Expanded Access program at this time. Participation in one of our ongoing clinical trials is the most appropriate way to access bexmarilimab and other investigational therapies. We encourage patients to speak with their physicians about the possibility of enrolling in a clinical trial listed on ClinicalTrials.gov.
Revisions to the Policy
Consistent with the 21st Century Cures Act, Faron Pharmaceuticals may revise this policy at any time without prior notice. Updates to the policy will be made available on this directory, our website and through appropriate communication channels.